소아 뇌종양 시장 규모는 향후 몇 년 동안 큰 폭의 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 정밀 의학, 분자 프로파일링, 표적 치료, 의료 인프라 증가, 보험 적용 범위 확대 등의 발전에 기인합니다. 주요 동향으로는 자기공명영상(MRI), 양전자방출단층촬영(PET), 컴퓨터단층촬영(CT) 스캔 기술의 개선, 유전자 및 분자 프로파일링의 사용 증가, 표적 치료법의 개발, 면역 치료의 도입, 최소 침습 수술 기술의 부상 등이 있습니다.
개인 맞춤형 의약품에 대한 수요 증가는 소아 뇌종양 시장의 성장을 견인할 것으로 예상됩니다. 맞춤 의학은 개인의 유전적 프로필, 라이프스타일 및 특정 건강 요구 사항에 따라 치료 및 의료 결정을 맞춤화하는 의료 접근 방식입니다. 유전 연구의 발전, 진단 도구의 개선, 보다 정확하고 효과적인 치료법의 가능성으로 인해 맞춤 의학에 대한 수요가 증가하고 있습니다. 맞춤 의학은 어린이의 종양 유형, 유전자 돌연변이, 반응 패턴에 따라 치료법을 맞춤화함으로써 치료 결과를 개선하는 동시에 건강한 조직의 손상을 최소화하고 부작용을 줄입니다.예를 들어, 2024년 2월, 미국에 기반을 둔 의료 기관인 Personalized Medicine Coalition은 FDA가 2023년에 16개의 새로운 희귀 질환 맞춤형 치료제를 승인했으며, 이는 2022년의 6개에서 증가한 수치라고 보고했습니다. 결과적으로 맞춤형 의약품에 대한 수요 증가는 소아 뇌종양 시장의 확장을 촉진하고 있습니다.
소아 뇌종양 시장의 기업들은 표적 치료법을 개선하고 환자 치료 결과를 향상시키기 위해 II형 RAF 억제제와 같은 혁신적인 치료법을 개발하는 데 주력하고 있습니다. II형 RAF 억제제는 특히 종양 성장을 촉진하는 돌연변이가 있는 RAF 키나아제를 선택적으로 억제하는 방식으로 작용합니다. 이 억제제는 특정 소아 저등급 신경교종(pLGG) 아형에서 발견되는 비정상적인 RAF 단백질 구조를 표적으로 하여 종양 세포 증식 및 생존에 기여하는 잘못된 신호 경로를 효과적으로 방해합니다. 예를 들어, 2024년 4월 미국 생명공학 기업인 데이원 바이오파마슈티컬스(Day One Biopharmaceuticals)는 미국 식품의약국(FDA)이 특정 BRAF 변이가 있는 6개월 이상 환자의 재발성 또는 불응성 소아 저등급 신경교종(pLGG) 치료를 위해 OJEMDA(토보라페닙)를 신속 승인했다고 발표했습니다. 이번 승인으로 오젬다는 해당 환자군에서 BRAF 융합 또는 돌연변이를 표적으로 하는 최초의 FDA 승인 치료제로 기록되었습니다. 이번 결정은 전체 반응률이 51%에 달해 이전 치료에 반응하지 않은 소아 뇌종양 치료에 대한 약물의 효능을 입증한 FIREFLY-1 임상시험의 데이터를 기반으로 이루어졌습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 소아 뇌종양 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 소아 뇌종양 시장 : 성장률 분석
- 세계의 소아 뇌종양 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 소아 뇌종양 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 소아 뇌종양 총 시장 규모(TAM)
제6장 시장 세분화
- 세계의 소아 뇌종양 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 신경 교종
- 혼합 신경교 교세포 종양
- 배아 종양
- 맥락막 신경총 유두종 또는 암종
- 비신경 상피 조직 유래 종양
- 수막 종양
- 세계의 소아 뇌종양 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 수술
- 방사선 치료
- 화학 치료
- 표적 치료
- 면역 치료
- 세계의 소아뇌 종양 시장 : 진단 방법별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 화상 기술
- 생검
- 신경학적 검사
- 요추천자
- 세계의 소아뇌 종양 시장 : 연령층별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 영아
- 소아
- 어린이
- 청소년
- 세계의 소아뇌 종양 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 및 진료소
- 의료 연구센터
- 학술기관
- 기타 용도
- 세계의 소아뇌종양 시장 : 신경 교종 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 저악성도 신경교종
- 고악성도 신경교종
- 세계의 소아 뇌종양 시장 : 혼합 신경교 교세포 종양 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 신경교종
- 이형성 신경 상피 종양(DNET)
- 세계의 소아 뇌종양 시장 : 배아 종양 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 수모종
- 비정형 테라토이드 횡문근 종양(ATRT)
- 원시 신경외배엽 종양(PNET)
- 세계의 소아 뇌종양 시장 : 맥락막 신경총 유두종 또는 암종 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 맥락막 신경총 유두종
- 맥락막 신경총 암종
- 세계의 소아 뇌종양 시장 : 비신경 상피 조직 유래 종양 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 횡문근육종
- 유잉육종
- 세계의 소아뇌종양 시장 : 수막 종양 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 수막종
- 혈관모세포종
제7장 지역별 및 국가별 분석
- 세계의 소아 뇌종양 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 소아 뇌종양 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 소아 뇌종양 시장 : 경쟁 구도
- 소아 뇌종양 시장 : 기업 프로파일
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Roche Holding AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Takeda Pharmaceutical Company 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- UCLA Health
- Ipsen Pharma
- Novocure
- Blueprint Medicines
- Karyopharm Therapeutics Inc.
- Renaissance Pharma
- Servier Laboratories
- Matica Biotechnology
- Curis Inc.
- Oncoheroes Biosciences
- Treovir Inc.
- Plus Therapeutics Inc.
- Stemline Therapeutics Inc.
- BrainChild Bio Inc.
- Seattle Children's Therapeutics
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 소아 뇌종양 시장(2029년) : 새로운 기회를 제공하는 국가
- 소아 뇌종양 시장(2029년) : 새로운 기회를 제공하는 부문
- 소아 뇌종양 시장(2029년) : 성장 전략
제36장 부록
HBR
Pediatric brain tumors are abnormal cell growths in the brain or central nervous system (CNS) of children, which can be either benign (non-cancerous) or malignant (cancerous). These tumors may develop in different areas of the brain or spinal cord, with treatment aimed at shrinking or removing the tumor, alleviating symptoms, and preserving cognitive and motor functions to support the child's long-term health and development.
The primary types of pediatric brain tumors include gliomas, mixed neuronal-glial tumors, embryonal tumors, choroid plexus papilloma or carcinoma, tumors arising from non-neuroepithelial tissue, and meningeal tumors. Gliomas are the most common type, originating from glial cells and requiring aggressive treatment due to their infiltrative growth and high recurrence potential. Treatment options include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, while diagnostic methods involve imaging techniques, biopsy, neurological exams, and lumbar puncture. Pediatric brain tumors can occur in various age groups, including infants, toddlers, children, and adolescents, and are managed in settings such as hospitals and clinics, medical research centers, academic institutes, and others.
The pediatric brain tumor market research report is one of a series of new reports from The Business Research Company that provides pediatric brain tumor market statistics, including the pediatric brain tumor industry global market size, regional shares, competitors with the pediatric brain tumor market share, detailed pediatric brain tumor market segments, market trends, and opportunities, and any further data you may need to thrive in the pediatric brain tumor industry. This pediatric brain tumor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The pediatric brain tumor market size has grown strongly in recent years. It will grow from $1.4 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the increasing incidence of pediatric brain tumors, the rise of emerging economies, growing investment in research and development, the increasing demand for advanced diagnostic technology, and the global rise in pediatric tumor cases.
The pediatric brain tumor market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to the advancements in precision medicine, molecular profiling, targeted therapy, rising healthcare infrastructure, and extended insurance coverage. Major trends include improvements in magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT) scanning technologies, the increasing use of genetic and molecular profiling, the development of targeted therapies, the introduction of immunotherapies, and the rise of minimally invasive surgical techniques.
The increasing demand for personalized medicine is expected to drive growth in the pediatric brain tumors market. Personalized medicine is a healthcare approach that tailors treatments and medical decisions to an individual's genetic profile, lifestyle, and specific health needs. The demand for personalized medicine is rising due to advancements in genetic research, improved diagnostic tools, and the potential for more precise and effective treatments. By customizing therapies based on a child's tumor type, genetic mutations, and response patterns, personalized medicine enhances treatment outcomes while minimizing damage to healthy tissue and reducing side effects. For instance, in February 2024, the Personalized Medicine Coalition, a US-based healthcare organization, reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, up from six in 2022. As a result, the growing demand for personalized medicine is fueling the expansion of the pediatric brain tumor market.
Companies in the pediatric brain tumors market are focusing on developing innovative treatments such as type II RAF inhibitors to improve targeted therapies and enhance patient outcomes. Type II RAF inhibitors work by selectively inhibiting RAF kinases, particularly those with mutations that promote tumor growth. These inhibitors target abnormal RAF protein structures found in certain pediatric low-grade glioma (pLGG) subtypes, effectively disrupting faulty signaling pathways that contribute to tumor cell proliferation and survival. For example, in April 2024, Day One Biopharmaceuticals, a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for OJEMDA (tovorafenib) for the treatment of relapsed or refractory pediatric low-grade glioma (pLGG) in patients aged six months and older with specific BRAF alterations. This approval marks OJEMDA as the first FDA-approved therapy targeting BRAF fusions or mutations in this patient group. The decision was based on data from the FIREFLY-1 clinical trial, which demonstrated an overall response rate of 51%, highlighting the drug's efficacy in treating pediatric brain tumors that have not responded to prior treatments.
In July 2024, Ipsen, a France-based biopharmaceutical company, entered into a partnership with Day One Biopharmaceuticals to commercialize tovorafenib for pediatric low-grade glioma (pLGG) outside the United States. Through this collaboration, Ipsen will manage the regulatory and commercial aspects of tovorafenib's global expansion. Day One Biopharmaceuticals, a US-based company specializing in treatments for childhood brain tumors, developed OJEMDA to address the unmet medical needs of pediatric patients.
Major players in the pediatric brain tumors market are AbbVie Inc., Bayer AG, Novartis AG, Roche Holding AG, Takeda Pharmaceutical Company, UCLA Health, Ipsen Pharma, Novocure, Blueprint Medicines, Karyopharm Therapeutics Inc., Renaissance Pharma, Servier Laboratories, Matica Biotechnology, Curis Inc., Oncoheroes Biosciences, Treovir Inc., Plus Therapeutics Inc., Stemline Therapeutics Inc., BrainChild Bio Inc., and Seattle Children's Therapeutics
North America was the largest region in the pediatric brain tumors market in 2024. The regions covered in pediatric brain tumors report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pediatric brain tumors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pediatric brain tumor market consists of revenues earned by entities providing services such as neuro-oncology care, rehabilitation services, psychosocial support, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric brain tumor market also includes sales of chemotherapy drugs, surgical instruments, and radiation therapy equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pediatric Brain Tumors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pediatric brain tumors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pediatric brain tumors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pediatric brain tumors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Gliomas; Mixed Neuronal-Glial Tumors; Embryonal Tumors; Choroid Plexus Papilloma Or Carcinoma; Tumors Arising From Non-Neuroepithelial Tissue; Meningeal Tumors
- 2) By Treatment Type: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Immunotherapy
- 3) By Diagnosis Method: Imaging Techniques; Biopsy; Neurological Exam; Lumbar Puncture
- 4) By Age Group: Infants; Toddlers; Children; Adolescents
- 5) By Application: Hospitals And Clinics; Medical Research Centers; Academic Institutes; Other Applications
- Subsegments:
- 1) By Gliomas: Low-Grade Gliomas; High-Grade Gliomas
- 2) By Mixed Neuronal-Glial Tumors: Gangliogliomas; Dysembryoplastic Neuroepithelial Tumors (DNET)
- 3) By Embryonal Tumors: Medulloblastoma; Atypical Teratoid Rhabdoid Tumor (ATRT); Primitive Neuroectodermal Tumors (PNET)
- 4) By Choroid Plexus Papilloma or Carcinoma: Choroid Plexus Papilloma; Choroid Plexus Carcinoma
- 5) By Tumors Arising from Non-Neuroepithelial Tissue: Rhabdomyosarcoma; Ewing's Sarcoma
- 6) By Meningeal Tumors: Meningiomas; Hemangiopericytomas
- Companies Mentioned:AbbVie Inc.; Bayer AG; Novartis AG; Roche Holding AG; Takeda Pharmaceutical Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Pediatric Brain Tumors Market Characteristics
3. Pediatric Brain Tumors Market Trends And Strategies
4. Pediatric Brain Tumors Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Pediatric Brain Tumors Growth Analysis And Strategic Analysis Framework
- 5.1. Global Pediatric Brain Tumors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Pediatric Brain Tumors Market Growth Rate Analysis
- 5.4. Global Pediatric Brain Tumors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Pediatric Brain Tumors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Pediatric Brain Tumors Total Addressable Market (TAM)
6. Pediatric Brain Tumors Market Segmentation
- 6.1. Global Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Gliomas
- Mixed Neuronal-Glial Tumors
- Embryonal Tumors
- Choroid Plexus Papilloma Or Carcinoma
- Tumors Arising From Non-Neuroepithelial Tissue
- Meningeal Tumors
- 6.2. Global Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Surgery
- Radiation Therapy
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- 6.3. Global Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Imaging Techniques
- Biopsy
- Neurological Exam
- Lumbar Puncture
- 6.4. Global Pediatric Brain Tumors Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Infants
- Toddlers
- Children
- Adolescents
- 6.5. Global Pediatric Brain Tumors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Medical Research Centers
- Academic Institutes
- Other Applications
- 6.6. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Gliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Low-Grade Gliomas
- High-Grade Gliomas
- 6.7. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Mixed Neuronal-Glial Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Gangliogliomas
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- 6.8. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Embryonal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medulloblastoma
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Primitive Neuroectodermal Tumors (PNET)
- 6.9. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Choroid Plexus Papilloma or Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Choroid Plexus Papilloma
- Choroid Plexus Carcinoma
- 6.10. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Tumors Arising from Non-Neuroepithelial Tissue, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Rhabdomyosarcoma
- Ewing's Sarcoma
- 6.11. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Meningeal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Meningiomas
- Hemangiopericytomas
7. Pediatric Brain Tumors Market Regional And Country Analysis
- 7.1. Global Pediatric Brain Tumors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Pediatric Brain Tumors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Pediatric Brain Tumors Market
- 8.1. Asia-Pacific Pediatric Brain Tumors Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Pediatric Brain Tumors Market
- 9.1. China Pediatric Brain Tumors Market Overview
- 9.2. China Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Pediatric Brain Tumors Market
- 10.1. India Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Pediatric Brain Tumors Market
- 11.1. Japan Pediatric Brain Tumors Market Overview
- 11.2. Japan Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Pediatric Brain Tumors Market
- 12.1. Australia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Pediatric Brain Tumors Market
- 13.1. Indonesia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Pediatric Brain Tumors Market
- 14.1. South Korea Pediatric Brain Tumors Market Overview
- 14.2. South Korea Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Pediatric Brain Tumors Market
- 15.1. Western Europe Pediatric Brain Tumors Market Overview
- 15.2. Western Europe Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Pediatric Brain Tumors Market
- 16.1. UK Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Pediatric Brain Tumors Market
- 17.1. Germany Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Pediatric Brain Tumors Market
- 18.1. France Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Pediatric Brain Tumors Market
- 19.1. Italy Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Pediatric Brain Tumors Market
- 20.1. Spain Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Pediatric Brain Tumors Market
- 21.1. Eastern Europe Pediatric Brain Tumors Market Overview
- 21.2. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Pediatric Brain Tumors Market
- 22.1. Russia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Pediatric Brain Tumors Market
- 23.1. North America Pediatric Brain Tumors Market Overview
- 23.2. North America Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Pediatric Brain Tumors Market
- 24.1. USA Pediatric Brain Tumors Market Overview
- 24.2. USA Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Pediatric Brain Tumors Market
- 25.1. Canada Pediatric Brain Tumors Market Overview
- 25.2. Canada Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Pediatric Brain Tumors Market
- 26.1. South America Pediatric Brain Tumors Market Overview
- 26.2. South America Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Pediatric Brain Tumors Market
- 27.1. Brazil Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Pediatric Brain Tumors Market
- 28.1. Middle East Pediatric Brain Tumors Market Overview
- 28.2. Middle East Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Pediatric Brain Tumors Market
- 29.1. Africa Pediatric Brain Tumors Market Overview
- 29.2. Africa Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Pediatric Brain Tumors Market Competitive Landscape And Company Profiles
- 30.1. Pediatric Brain Tumors Market Competitive Landscape
- 30.2. Pediatric Brain Tumors Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis
31. Pediatric Brain Tumors Market Other Major And Innovative Companies
- 31.1. UCLA Health
- 31.2. Ipsen Pharma
- 31.3. Novocure
- 31.4. Blueprint Medicines
- 31.5. Karyopharm Therapeutics Inc.
- 31.6. Renaissance Pharma
- 31.7. Servier Laboratories
- 31.8. Matica Biotechnology
- 31.9. Curis Inc.
- 31.10. Oncoheroes Biosciences
- 31.11. Treovir Inc.
- 31.12. Plus Therapeutics Inc.
- 31.13. Stemline Therapeutics Inc.
- 31.14. BrainChild Bio Inc.
- 31.15. Seattle Children's Therapeutics
32. Global Pediatric Brain Tumors Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Pediatric Brain Tumors Market
34. Recent Developments In The Pediatric Brain Tumors Market
35. Pediatric Brain Tumors Market High Potential Countries, Segments and Strategies
- 35.1 Pediatric Brain Tumors Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Pediatric Brain Tumors Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Pediatric Brain Tumors Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
